Article
Apicoplast ribosomal protein S10-V127M enhances artemisinin resistance of a Kelch13 transgenic Plasmodium falciparum.
Malaria journal - 27 Oct 2022
Kampoun Tanyaluck, Srichairatanakool Somdet, Prommana Parichat, Shaw Philip J, Green Judith L, Knuepfer Ellen, Holder Anthony A, Uthaipibull Chairat
Abstract excerpt
BACKGROUND: The resistance of Plasmodium falciparum to artemisinin-based (ART) drugs, the front-line drug family used in artemisinin-based combination therapy (ACT) for treatment of malaria, is of great concern. Mutations in the kelch13 (k13) gene (for example, those resulting in the Cys580Tyr [C580Y] variant) were identified as genetic markers for ART-resistant parasites, which suggests they are associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
